WA
SUPN icon

Whitebox Advisors’s Supernus Pharmaceuticals SUPN Stock Holding History

Whitebox Advisors’s Portfolio SUPN Stock Details SUPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-75,415
Closed -$1.01M – 137
2015
Q4 		$1.01M Buy
+75,415
New +$1.17M 0.03% 157
2015
Q3 		– Sell
-140,147
Closed -$2.38M – 385
2015
Q2 		$2.38M Sell
140,147
-314,649
-69% -$4.48M 0.1% 190
2015
Q1 		$5.5M Buy
454,796
+34,707
+8% +$328K 0.21% 97
2014
Q4 		$3.49M Sell
420,089
-4,202
-1% -$35.3K 0.14% 126
2014
Q3 		$3.69M Buy
424,291
+170,047
+67% +$1.54M 0.14% 135
2014
Q2 		$2.78M Buy
254,244
+47,327
+23% +$422K 0.11% 172
2014
Q1 		$1.85M Buy
+206,917
New +$1.91M 0.08% 197

Other funds holding SUPN

BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
Apex Capital Management Dayton, Ohio $4.54B AUM 1.74% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
NPIC
Neumeier Poma Investment Counsel Carmel, California $1.21B AUM 70.48% 1-Year Est. Return

Whitebox Advisors's SUPN Position: Q1 2016 in Review

Whitebox Advisors sold out of Supernus Pharmaceuticals (SUPN) in Q1 2016, closing a stake of 75,415 shares — an estimated $1.01M sold.

Whitebox Advisors first reported a position in SUPN in Q1 2014 and held it in 7 quarters. The position peaked at $5.5M in Q1 2015. 213 funds tracked by Wall St. Rank hold SUPN as of Q1 2016.

  • Whitebox Advisors reported no remaining Supernus Pharmaceuticals position as of Q1 2016 after selling out during the quarter.
  • Whitebox Advisors sold 75,415 Supernus Pharmaceuticals shares in Q1 2016, an estimated $1.01M.
  • Whitebox Advisors first reported a position in Supernus Pharmaceuticals in Q1 2014 and held it in 7 quarters.
  • Whitebox Advisors's Supernus Pharmaceuticals position peaked at $5.5M in Q1 2015.
  • 213 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q1 2016.

Based on Whitebox Advisors's 13F filing for Q1 2016, filed 3 May 2016.